Correlation Between Bristol Myers and BKV

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and BKV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and BKV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and BKV Corporation, you can compare the effects of market volatilities on Bristol Myers and BKV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of BKV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and BKV.

Diversification Opportunities for Bristol Myers and BKV

0.53

Correlation Coefficient

Bristol Myers  BKV

Very weak diversification

The 3 months correlation between Bristol and BKV is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and BKV Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BKV Corporation and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with BKV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BKV Corporation has no effect on the direction of Bristol Myers i.e., Bristol Myers and BKV go up and down completely randomly.

Pair Corralation between Bristol Myers and BKV

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the BKV. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 1.17 times less risky than BKV. The stock trades about -0.01 of its potential returns per unit of risk. The BKV Corporation is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  1,800  in BKV Corporation on September 24, 2024 and sell it today you would earn a total of  397.00  from holding BKV Corporation or generate 22.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	12.65%
Values	Daily Returns

Bristol Myers Squibb  vs.  BKV Corp.

Bristol Myers Squibb

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

BKV Corporation

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BKV Corporation are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward-looking signals, BKV showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and BKV

The main advantage of trading using opposite Bristol Myers and BKV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, BKV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BKV will offset losses from the drop in BKV's long position.

The idea behind Bristol Myers Squibb and BKV Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.